U.S. Residential REITs Stock News

Why Canaan’s latest numbers matter for shareholders Canaan (NasdaqGM:CAN) just released fourth quarter and full year 2025 results, fresh earnings guidance for the first quarter of 2026, and January Bitcoin production data, giving investors several new reference points to assess the stock. For the fourth quarter ended December 31, 2025, Canaan reported revenue of US$196.27 million, compared with US$88.77 million a year earlier. The company recorded a net loss of US$85.04 million for the...

Recent analyst calls around Globus Medical (GMED) have sharpened the market’s focus on the stock, following positive preliminary fourth quarter revenue, commentary on margin expansion, and fresh coverage tied to Nevro, international growth, and enabling technologies. See our latest analysis for Globus Medical. The recent upgrade and new coverage come after a period where short term share price momentum has cooled, with a 30 day share price return showing a 4.78% decline. In contrast, the 3...

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench. These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance. Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...

The Brink’s Company has appointed Adrian Button as executive vice president and president of Brink’s North America, effective February 16, 2026, adding him to the executive leadership team reporting to CEO Mark Eubanks. With more than 30 years of global operational leadership at GE, NCR, and Carrier overseeing multibillion-dollar businesses and large-scale supply chains, Button’s background directly aligns with Brink’s focus on operational efficiency and service quality in North...

If you are wondering whether Texas Capital Bancshares at around US$104 is offering good value or asking too much, you are in the right place. The stock closed at US$104.37 recently, with returns of 1.3% over the last week, 6.5% over the last month, 13.8% year to date, 27.0% over one year and 60.3% over three years, as well as 30.9% over five years. These moves may have shifted how the market views its potential and risks. Recent coverage around Texas Capital Bancshares has focused on its...

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing 515 points and the S&P 500 nearing a record high. Amid this positive momentum, investors may find opportunities in stocks that appear to be trading below their estimated fair value, potentially offering attractive entry points in a market characterized by robust gains and evolving economic conditions.

As February 2026 kicks off, major stock indexes in the United States have shown impressive gains, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In such a buoyant market atmosphere, investors often look beyond established giants to explore opportunities in lesser-known areas like penny stocks. Although 'penny stock' is an older term, it still denotes smaller or newer companies that can offer significant potential when backed by strong...

Otter Tail (OTTR) has just posted its FY 2025 numbers, with fourth quarter revenue of US$308.1 million and basic EPS of US$1.24, alongside trailing twelve month revenue of about US$1.3 billion and EPS of US$6.59 setting the backdrop. Over recent periods, revenue has ranged from US$303.1 million in Q4 2024 to US$337.4 million in Q1 2025, while quarterly EPS has moved between US$1.31 and US$2.04, giving investors a clear read on how margins are holding up against this revenue base. With a...

Insider lock up extension puts Regencell Bioscience Holdings (RGC) insider activity in focus Regencell Bioscience Holdings (RGC) has extended insider lock up commitments for directors and employees by one year, covering previously granted stock options and keeping insiders restricted from selling for a longer period. See our latest analysis for Regencell Bioscience Holdings. The lock up extension comes after a sharp shift in sentiment, with a 90 day share price return of 150.16% and year to...

Baxter International Inc. reported past fourth-quarter 2025 sales of US$2,974 million, up from US$2,753 million a year earlier, but the company’s net loss widened to US$1,128 million amid higher goodwill impairments and ongoing margin pressures. Alongside reaffirming a modest quarterly dividend and completing a long-running share repurchase program, Baxter guided to flat to 1% U.S. GAAP sales growth for 2026, underscoring a focus on balance sheet repair and operational reshaping following...

Post Holdings has recently reported first-quarter 2026 results, completed a US$122.1 million buyback tranche, authorized a new US$500 million repurchase program, amended its articles of incorporation, and announced several leadership changes, including a new CEO for Post Consumer Brands and two additions to its Board. These moves collectively highlight Post’s focus on capital returns and governance, while placing fresh leadership at the center of its largest consumer and pet food...

If you are wondering whether eXp World Holdings at around US$7.50 is a bargain or a value trap, you are not alone, and this article is built to help you frame that question clearly. The share price is around US$7.50, with returns of 2.7% decline over 7 days, 21.4% decline over 30 days, 17.6% decline year to date, 32.3% decline over 1 year and 41.2% decline over 3 years. This raises fair questions about how the market currently views its prospects and risks. Recent news coverage has focused...

International General Insurance Holdings Ltd. recently reported that analysts expected a year-over-year earnings decline alongside higher revenues for the quarter ended December 2025, ahead of its earnings release on February 24. This combination of weaker earnings and stronger top-line performance has sharpened attention on how management will frame business conditions and future profitability during the earnings call. We’ll now examine how anticipation of lower earnings despite higher...

Gentex Corporation recently launched the Ops-Core Voice Projection Unit (VPU), an add-on to its Special Operations Tactical Respirator that enhances mission-critical voice clarity with three adjustable volume levels and integration into existing communication systems for tactical operators. This move extends Gentex’s communication suite beyond its core automotive and dimmable glass products, highlighting how defense-oriented innovation can broaden its end-market exposure. Next, we’ll examine...

Fluor (FLR) capped FY 2025 with Q4 revenue of US$4.2 billion and a basic EPS loss of US$9.77, alongside a net loss excluding extra items of US$1.6 billion that keeps profitability in focus for investors. The company has seen quarterly revenue move between US$3.4 billion and US$4.3 billion over the past six reported periods, while basic EPS has swung from a profit of US$14.91 in Q2 2025 to losses such as US$4.30 in Q3 2025, setting a volatile earnings backdrop for today’s release. With...

In February 2026, MasterBrand, Inc. reported fourth-quarter 2025 sales of US$644.6 million, a net loss of US$42 million, and a sharp drop in full-year net income to US$26.7 million despite slightly higher annual sales of US$2.73 billion. The company also projected a mid-to-high single-digit year-over-year decline in first-quarter 2026 net sales and disclosed that it had effectively paused share repurchases after buying back 226,914 shares earlier under its existing program. We will now...

Insiders who bought US$666.6k worth of Sportsman's Warehouse Holdings, Inc.'s ( NASDAQ:SPWH ) stock at an average buy...

Wondering if Fresh Del Monte Produce at around US$40.32 is offering good value for the risk you are taking, or if the recent optimism has already been priced in. The stock has returned 3.2% over the last 7 days, 9.2% over 30 days, 14.2% year to date, 38.3% over 1 year and 55.7% over 3 years, with a 5 year return of 69.9%. This naturally raises questions about what is baked into the current share price. Recent coverage around the company has focused on its position as a global fresh produce...

Piedmont Realty Trust recently reported its fourth-quarter and full-year 2025 results, with quarterly revenue of US$142.85 million and a quarterly net loss of US$43.25 million, while full-year revenue reached US$564.99 million alongside a full-year net loss of US$83.62 million. The results show sales and revenue holding roughly flat year over year, but losses per share from continuing operations widened for both the quarter and the full year, highlighting ongoing profitability pressure...

How Has VSE's Share Price Been Moving? Before you think about whether VSE fits in your portfolio, it helps to ask a simple question: are you paying up for a story or paying a fair price for the cash flows behind the ticker? Over the short term, VSE's share price shows mixed moves, with a 1.0% return over the last 7 days and a 0.4% decline over the past month. The longer backdrop includes a 17.7% year to date return and a 115.4% return over the last year, as well as a very large gain over 5...

DTE Energy FY 2025 Earnings Snapshot DTE Energy (DTE) has wrapped up FY 2025 with fourth quarter revenue of US$4.4 billion and basic EPS of US$1.80, setting the tone for how investors assess the full year. The company has seen quarterly revenue range from US$3.4 billion to US$4.4 billion over 2025, while basic EPS moved between US$1.10 and US$2.14. This gives a clear view of how the top line and per share earnings have tracked across the year. With a trailing net profit margin of 9.2% versus...

If you are looking at Black Stone Minerals and wondering whether the current price offers solid value, this article will walk you through what the numbers are really saying. The stock last closed at US$15.25, with returns of 0.7% over 7 days, 8.2% over 30 days, 12.9% year to date, 12.0% over 1 year, 34.1% over 3 years and a very large gain over 5 years of 169.4%. Recent price moves sit against a backdrop of ongoing investor interest in energy royalty and mineral rights businesses. In these...

If you are wondering whether Conagra Brands at around US$18.89 is a bargain or a value trap today, this article will help you assess what the current share price really reflects. The stock has recently shown mixed returns, with an 11.4% gain over 30 days and 9.2% year to date, set against a 15.0% decline over 1 year and a 38.7% decline over 3 years. Recent coverage has focused on how Conagra Brands fits into the packaged foods sector, including commentary on its brand portfolio and cost...

Humana’s CenterWell has acquired MaxHealth, a primary care provider in Florida. The deal significantly broadens CenterWell’s primary care presence across the state. The acquisition supports Humana’s value based care model for Medicare and other patients. For investors watching NYSE:HUM, this move comes with the stock trading around $184.99 and showing mixed recent performance. Shares are up 2.0% over the past week but have seen declines of 32.3% over 30 days and 30.1% year to date. Over...